Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Ana Paula Landi-Librandi, Taís Nader Chrysostomo, Ana Elisa Caleiro Seixas Azzolini, Cleni Mara Marzocchi-Machado, Carlos Alberto de Oliveira & Yara Maria Lucisano-Valim. (2012) Study of quercetin-loaded liposomes as potential drug carriers: in vitro evaluation of human complement activation. Journal of Liposome Research 22:2, pages 89-99.
Read now
Read now
Janos Szebeni & Carl R. Alving. (1999) Complement-Mediated Acute Effects of Liposome-Encapsulated Hemoglobin. Artificial Cells, Blood Substitutes, and Biotechnology 27:1, pages 23-41.
Read now
Read now
Deepank R. Utkhede & Colin P. Tilcock. (1998) Studies Upon the Toxicity of Polyethylene Glycol Coated Lipid Vesicles: Acute Hemodynamic Effects, Pyrogenicity and Complement Activation. Journal of Liposome Research 8:4, pages 537-550.
Read now
Read now
Janos Szebeni, Helmut Spielberg, Richard O. Cliff, Nabila M. Wassef, Alan S. Rudolph & Carl R. Alving. (1997) Complement Activation and Thromboxane Secretion by Liposome-Encapsulated Hemoglobin in Rats in Vivo: Inhibition by Soluble Complement Receptor Type 1. Artificial Cells, Blood Substitutes, and Biotechnology 25:4, pages 347-355.
Read now
Read now
Tony L. Whateley. (1996) Literature Alerts. Drug Delivery 3:2, pages 127-136.
Read now
Read now
Tony L. Whateley. (1996) Literature Alerts. Drug Delivery 3:3, pages 201-218.
Read now
Read now
Articles from other publishers (13)
Claire K. Holley, Edward Cedrone, Duncan Donohue, Barry W. Neun, Daniela Verthelyi, Eric S. Pang & Marina A. Dobrovolskaia. (2021) An In Vitro Assessment of Immunostimulatory Responses to Ten Model Innate Immune Response Modulating Impurities (IIRMIs) and Peptide Drug Product, Teriparatide. Molecules 26:24, pages 7461.
Crossref
Crossref
Gergely Tibor Kozma, Tamás Mészáros, Tamás Bakos, Mark Hennies, Dániel Bencze, Barbara Uzonyi, Balázs Győrffy, Edward Cedrone, Marina A. Dobrovolskaia, Mihály Józsi & János Szebeni. (2021) Mini-Factor H Modulates Complement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC) Model: Potential Benefits Against Cytokine Storm. Frontiers in Immunology 12.
Crossref
Crossref
Barry Neun, Yechezkel Barenholz, Janos Szebeni & Marina Dobrovolskaia. (2018) Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro. Molecules 23:7, pages 1700.
Crossref
Crossref
Edward Cedrone, Barry Neun, Jamie Rodriguez, Alison Vermilya, Jeffrey Clogston, Scott McNeil, Yechezkel Barenholz, Janos Szebeni & Marina Dobrovolskaia. (2017) Anticoagulants Influence the Performance of In Vitro Assays Intended for Characterization of Nanotechnology-Based Formulations. Molecules 23:1, pages 12.
Crossref
Crossref
Marina A. Dobrovolskaia. (2015) Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy. Journal of Controlled Release 220, pages 571-583.
Crossref
Crossref
Hiromi Sakai, Yuji Suzuki, Keitaro Sou & Mayumi Kano. (2012) Cardiopulmonary hemodynamic responses to the small injection of hemoglobin vesicles (artificial oxygen carriers) in miniature pigs. Journal of Biomedical Materials Research Part A 100A:10, pages 2668-2677.
Crossref
Crossref
János Szebeni, Péter Bedőcs, Zoltán Rozsnyay, Zsóka Weiszhár, Rudolf Urbanics, László Rosivall, Rivka Cohen, Olga Garbuzenko, György Báthori, Miklós Tóth, Rolf Bünger & Yechezkel Barenholz. (2012) Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome. Nanomedicine: Nanotechnology, Biology and Medicine 8:2, pages 176-184.
Crossref
Crossref
. (2004) VERTEPORFIN THERAPY OF SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION. RETINA 24:1, pages 1-12.
Crossref
Crossref
Janos SzebeniLajos BaranyiSandor SavayMihaly BodoDavid S. MorseMilan Basta, Gregory L. StahlRolf Bünger & Carl R. Alving. (2000) Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction. American Journal of Physiology-Heart and Circulatory Physiology 279:3, pages H1319-H1328.
Crossref
Crossref
WERNER KRAUSE, SILKE GERLACH & PETER MUSCHICK. (2000) Prevention of the Hemodynamic Effects of Iopromide-Carrying Liposomes in Rats and Pigs. Investigative Radiology 35:8, pages 493-503.
Crossref
Crossref
Beth Goins, William T. Phillips, Robert Klipper & Alan S. Rudolph. (1997) Role of Complement in Rats Injected with Liposome-Encapsulated Hemoglobin. Journal of Surgical Research 68:2, pages 99-105.
Crossref
Crossref
J. Szebeni, N.M. Wassef, K.R. Hartman, A.S. Rudolph & C.R. Alving. (2003) Complement activation in vitro by the red cell substitute, liposome‐ encapsulated hemoglobin: mechanism of activation and inhibition by soluble complement receptor type 1. Transfusion 37:2, pages 150-159.
Crossref
Crossref
Janos Szebeni, Nabila M. Wassef, Alan S. Rudolph & Carl R. Alving. (1996) Complement activation in human serum by liposome-encapsulated hemoglobin: the role of natural anti-phospholipid antibodies. Biochimica et Biophysica Acta (BBA) - Biomembranes 1285:2, pages 127-130.
Crossref
Crossref